# Iantrek

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/iantrek

- Industry: Medical Devices & Equipment
- Headquarters: White Plains, US
- Website: www.iantrekmed.com
- Total disclosed funding: $50M
- Latest round: Series C (Aug 19, 2025)
- Investors on record: 6

## About

Based in New York, US, and founded in 2019, Iantrek operates as an ophthalmic medical device company. The company was founded by its CEO Sean Ianchulev. In August 2025, Iantrek, Inc. raised USD 42 million in series C funding co-led by new investors US Venture Partners and aMoon Fund, with participation from returning investors Visionary Venture Fund, Sectoral Asset Management, Radius Special Situations Fund, and Civilization Ventures. Iantrek develops various medical devices, including micro-interventional glaucoma surgical (MIGS) devices. The MIGS products are focused on the applications of aqueous outflow pathways, trabecular and suprachoroidal. The company’s product line includes CycloPen™, a micro-interventional device that focuses on the suprachoroidal outflow channel; and Hydrus® Microstent. The company will use the August 2025 funding to to improve surgical access to the uveoscleral pathway.

## Funding rounds

- Series C, Aug 19, 2025, $35M — US Venture Partners, Sectoral Asset Management, Visionary Venture Fund, aMoon, Civilization Ventures, Radius Special Situations Fund
- Series B, Aug 4, 2022, $15M — Sectoral Asset Management, Visionary Venture Fund

## Investors

- Sectoral Asset Management (https://capitalatlas.ai/funds/sectoral-asset-management) — Series B, Series C
- Visionary Venture Fund (https://capitalatlas.ai/funds/visionary-venture-fund) — Series B, Series C
- US Venture Partners (https://capitalatlas.ai/funds/us-venture-partners) — Series C
- aMoon (https://capitalatlas.ai/funds/amoon) — Series C
- Civilization Ventures (https://capitalatlas.ai/funds/civilization-ventures) — Series C
- Radius Special Situations Fund — Series C